Market news
CRYSTAL LAKE, Ill., September 14, 2026--Aptar and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery
Aptar's ACT-101 is designed to intervene a step earlier than current CF modulators.
The custom pump has a 24/410 screw-on neck finish, with the actuator and collar enlarged to fit the broader bottle shape.
Detailed price information for Aptargroup (ATR-N) from The Globe and Mail including charting and trades.
Record $1B revenue as pharma growth offsets margin pressure.
CRYSTAL LAKE, Ill., July 30, 2026--Aptar Reports Second Quarter 2026 Results
AptarGroup, Inc., a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it has been named one of the World’ s Most Sustainable Companies 2026 by TIME for the third consecutive year. Aptar is ranked 261 out of 750 global companies evaluated by TIME and its partner Statista.
CRYSTAL LAKE, Ill., July 22, 2026--Aptar Pharma announces MHRA GMP certification at its Nanopharm facililty, expanding regulated analytical testing for OINDPs in Europe.
The framework combines Aptar Pharma’s elastomeric experience and a network of partners across the injectable drugs sector.
CRYSTAL LAKE, Ill., July 20, 2026--Aptar Beauty Launches Next-Generation Auto-Loading Dropper Technology for Easier, More Accurate Skincare Dosing
CRYSTAL LAKE, Ill., July 16, 2026--Aptar Declares Quarterly Dividend
CRYSTAL LAKE, Ill., July 13, 2026--Aptar Named Among Top 100 of America’s Best Companies by TIME
The closures are designed to improve product protection during fulfilment and delivery while aligning with recycling goals.
This is the newest page. Registered accounts read further back.